Filing Details

Accession Number:
0001127602-12-023276
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-31 20:31:50
Reporting Period:
2012-07-27
Filing Date:
2012-07-31
Accepted Time:
2012-07-31 19:31:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318154 Amgen Inc AMGN Biological Products, (No Disgnostic Substances) (2836) 953540776
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1183903 Fabrizio Bonanni One Amgen Center Drive
Thousand Oaks CA 91320-1799
Evp, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-27 42,109 $71.88 115,608 No 4 M Direct
Common Stock Acquisiton 2012-07-27 41,902 $62.55 157,510 No 4 M Direct
Common Stock Acquisiton 2012-07-27 30,000 $56.79 187,510 No 4 M Direct
Common Stock Acquisiton 2012-07-27 84,000 $42.13 271,510 No 4 M Direct
Common Stock Acquisiton 2012-07-27 63,000 $50.44 334,510 No 4 M Direct
Common Stock Acquisiton 2012-07-27 42,000 $58.43 376,510 No 4 M Direct
Common Stock Acquisiton 2012-07-27 303,011 $0.00 363,639 No 5 G Indirect By Family Trust
Common Stock Disposition 2012-07-27 303,011 $0.00 73,499 No 5 G Direct
Common Stock Disposition 2012-07-27 303,011 $82.14 60,628 No 4 S Indirect By Family Trust
Common Stock Disposition 2012-07-30 12,137 $84.33 48,491 No 4 S Indirect By Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 5 G Indirect By Family Trust
No 5 G Direct
No 4 S Indirect By Family Trust
No 4 S Indirect By Family Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nqso (Right to Buy) Disposition 2012-07-27 42,109 $0.00 42,109 $71.88
Common Stock Nqso (Right to Buy) Disposition 2012-07-27 41,902 $0.00 41,902 $62.55
Common Stock Nqso (Right to Buy) Disposition 2012-07-27 30,000 $0.00 30,000 $56.79
Common Stock Nqso (Right to Buy) Disposition 2012-07-27 84,000 $0.00 84,000 $42.13
Common Stock Nqso (Right to Buy) Disposition 2012-07-27 63,000 $0.00 63,000 $50.44
Common Stock Nqso (Right to Buy) Disposition 2012-07-27 42,000 $0.00 42,000 $58.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2007-04-03 2013-04-03 No 4 M Direct
0 2008-04-26 2014-04-26 No 4 M Direct
0 2008-10-29 2014-10-29 No 4 M Direct
0 2009-04-29 2015-04-29 No 4 M Direct
21,000 2010-04-28 2016-04-28 No 4 M Direct
42,000 2011-04-26 2020-04-26 No 4 M Direct
Footnotes
  1. These shares are being transferred to the reporting person's Family Trust.
  2. These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  3. These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  4. The price reported is an average price. The prices ranged from $81.56 to $82.48 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
  5. The price reported is an average price. The prices ranged from $84.32 to $84.37 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.